Leben Suspended After UFC 138

LEBEN SUSPENDED FOR ONE YEAR AFTER FAILING UFC® 138 DRUG TEST
Zuffa, LLC, owner of the Ultimate Fighting Championship® (“the UFC®”), today released information stating that middleweight fighter Chris Leben tested positive for Oxycodone and Oxymorphone following his Nov. 5  loss to Mark Munoz in the main event of UFC® 138 in Birmingham, England.

As a result of the positive test, Leben will be suspended from fighting for one (1) year.

“I like Chris and I want him to do well, but based on his actions, he's been suspended for one year,” UFC President Dana White said. “If he needs professional help, we are going to be there for him. We want to see him succeed not only in the Octagon, but in his personal life.”

“I would like to make it known that I fully accept this suspension and apologize for embarrassing the UFC, my friends and family, and sport of mixed martial arts,” Leben said. “I’m learning that I’m my own worst enemy sometimes. I can’t succeed in the Octagon or in life behaving this way. I’ve got to make some real changes over the next year and I’m going to focus on getting my life and career back on track. Again, I’m sorry to the UFC and fans that’ve supported me since my days on The Ultimate Fighter.”

The remaining 19 fighters on the UFC® 138 card all passed their post fight drug tests.
 
Saturday, May 26
7pm/10pm
PTET
Las Vegas, Nevada

Media

Recent
Antonio "Bigfoot" Silva toppled a legend when he beat Fedor Emelianenko in the Strikeforce Heavyweight Grand Prix tournament - watch Silva's UFC debut Saturday, May 26 against Cain Velasquez.
May 25, 2012
UFC 146 press conference at MGM Grand on May 24, 2012 in Las Vegas, Nevada. (Photo by Josh Hedges/Zuffa LLC/Zuffa LLC via Getty Images)
May 24, 2012
Headliners Junior dos Santos and Frank Mir discuss knockouts vs. submissions, using the UFC® heavyweight championship belt as a pillow, language barriers and more at the UFC® 146 pre-fight press conference.
May 24, 2012
See all 10 heavyweight fighters at the UFC 146 pre-fight press conference.
May 22, 2012